Penny Daynes, Associate Regional Pharmacy procurement specialist at SPS, presents a summary of the resources published by SPS between 1st and 7th November.
To easily find a list of newly published pages go to sps.nhs.uk, select ‘search’, click in the search bar, and press enter.
Quick links to highlighted resources:
The licence and supporting evidence for ranibizumab biosimilars
Four licensed ranibizumab biosimilars are available: Byooviz, Ongavia, Rimmyrah and Ximluci. Learn about the licensed indications and supporting evidence
https://www.sps.nhs.uk/articles/the-licence-and-supporting-evidence-for-ranibizumab-biosimilar/
Preparing to use ranibizumab biosimilar
Ranibizumab biosimilar needs planning. Ensure you are familiar with the area and then develop an implementation plan working with the multidisciplinary team
https://www.sps.nhs.uk/articles/preparing-to-use-ranibizumab-biosimilar/
Restricted to NHS: The licence and supporting evidence for aflibercept biosimilars (log in required)
Aflibercept 2mg biosimilars Afqlir, Eydenzelt, Yesafili and Vgenfli are expected in December 2025 for NHS use. Learn about supporting evidence and differences.
https://www.sps.nhs.uk/articles/the-licence-and-supporting-evidence-for-aflibercept-biosimilars/
New Medicines News
New Medicines News is produced by the SPS Horizon Scanning Service. It highlights recent new product launches and significant medicines regulatory changes.
https://www.sps.nhs.uk/articles/new-medicines-news/
Medicines Governance Do Once (MGDO) programme opportunity
Contact jo.jenkins2@nhs.net for more information. Closing date for applications 30 November 2025.
Next events
Forthcoming webinars and conferences
https://www.sps.nhs.uk/home/events/next-events/
Join our new WhatsApp channel to stay up to date with our latest news and updates
https://whatsapp.com/channel/0029VbBslvuJpe8aH3n7Zu1i
Podcast description:
NHS Specialist Pharmacy Service serves healthcare professionals across the NHS who are involved in all aspects of buying, making and using medicines. Our motto is 'do once and share'.
All content for NHS Specialist Pharmacy Service is the property of NHS Specialist Pharmacy Service and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Penny Daynes, Associate Regional Pharmacy procurement specialist at SPS, presents a summary of the resources published by SPS between 1st and 7th November.
To easily find a list of newly published pages go to sps.nhs.uk, select ‘search’, click in the search bar, and press enter.
Quick links to highlighted resources:
The licence and supporting evidence for ranibizumab biosimilars
Four licensed ranibizumab biosimilars are available: Byooviz, Ongavia, Rimmyrah and Ximluci. Learn about the licensed indications and supporting evidence
https://www.sps.nhs.uk/articles/the-licence-and-supporting-evidence-for-ranibizumab-biosimilar/
Preparing to use ranibizumab biosimilar
Ranibizumab biosimilar needs planning. Ensure you are familiar with the area and then develop an implementation plan working with the multidisciplinary team
https://www.sps.nhs.uk/articles/preparing-to-use-ranibizumab-biosimilar/
Restricted to NHS: The licence and supporting evidence for aflibercept biosimilars (log in required)
Aflibercept 2mg biosimilars Afqlir, Eydenzelt, Yesafili and Vgenfli are expected in December 2025 for NHS use. Learn about supporting evidence and differences.
https://www.sps.nhs.uk/articles/the-licence-and-supporting-evidence-for-aflibercept-biosimilars/
New Medicines News
New Medicines News is produced by the SPS Horizon Scanning Service. It highlights recent new product launches and significant medicines regulatory changes.
https://www.sps.nhs.uk/articles/new-medicines-news/
Medicines Governance Do Once (MGDO) programme opportunity
Contact jo.jenkins2@nhs.net for more information. Closing date for applications 30 November 2025.
Next events
Forthcoming webinars and conferences
https://www.sps.nhs.uk/home/events/next-events/
Join our new WhatsApp channel to stay up to date with our latest news and updates
https://whatsapp.com/channel/0029VbBslvuJpe8aH3n7Zu1i
Podcast description:
NHS Specialist Pharmacy Service serves healthcare professionals across the NHS who are involved in all aspects of buying, making and using medicines. Our motto is 'do once and share'.
Primary care discussions: personalised evidence-based medicine to minimise polypharmacy
NHS Specialist Pharmacy Service
57 minutes 2 seconds
6 months ago
Primary care discussions: personalised evidence-based medicine to minimise polypharmacy
Audio from our webinar held on the 4 March 2025 which featured a facilitated case-based discussion about the complexities of polypharmacy and deprescribing. This was a follow on from our first webinar, which lays the foundations of some of the deprescribing tools available. (57m02s)
Speakers:
Lelly Oboh: Older people lead, NHS SPS
Jasvir Singh Dhillon: Clinical pharmacist, Shropshire, Telford & Wrekin ICB, & GP practices
Rakhi Aggarwal: Primary care lead, NHS SPS
NHS Specialist Pharmacy Service
Penny Daynes, Associate Regional Pharmacy procurement specialist at SPS, presents a summary of the resources published by SPS between 1st and 7th November.
To easily find a list of newly published pages go to sps.nhs.uk, select ‘search’, click in the search bar, and press enter.
Quick links to highlighted resources:
The licence and supporting evidence for ranibizumab biosimilars
Four licensed ranibizumab biosimilars are available: Byooviz, Ongavia, Rimmyrah and Ximluci. Learn about the licensed indications and supporting evidence
https://www.sps.nhs.uk/articles/the-licence-and-supporting-evidence-for-ranibizumab-biosimilar/
Preparing to use ranibizumab biosimilar
Ranibizumab biosimilar needs planning. Ensure you are familiar with the area and then develop an implementation plan working with the multidisciplinary team
https://www.sps.nhs.uk/articles/preparing-to-use-ranibizumab-biosimilar/
Restricted to NHS: The licence and supporting evidence for aflibercept biosimilars (log in required)
Aflibercept 2mg biosimilars Afqlir, Eydenzelt, Yesafili and Vgenfli are expected in December 2025 for NHS use. Learn about supporting evidence and differences.
https://www.sps.nhs.uk/articles/the-licence-and-supporting-evidence-for-aflibercept-biosimilars/
New Medicines News
New Medicines News is produced by the SPS Horizon Scanning Service. It highlights recent new product launches and significant medicines regulatory changes.
https://www.sps.nhs.uk/articles/new-medicines-news/
Medicines Governance Do Once (MGDO) programme opportunity
Contact jo.jenkins2@nhs.net for more information. Closing date for applications 30 November 2025.
Next events
Forthcoming webinars and conferences
https://www.sps.nhs.uk/home/events/next-events/
Join our new WhatsApp channel to stay up to date with our latest news and updates
https://whatsapp.com/channel/0029VbBslvuJpe8aH3n7Zu1i
Podcast description:
NHS Specialist Pharmacy Service serves healthcare professionals across the NHS who are involved in all aspects of buying, making and using medicines. Our motto is 'do once and share'.
